Is West Pharmaceutical Services Inc (WST) undervalued? · P/E 35, rev $2.89B
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
This page asks whether West Pharmaceutical Services Inc (WST) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
WST currently screens at market cap $15.97B and trailing P/E 34.8. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new WST 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare WST to the stock page model before you treat a low multiple as a gift.
Not investment advice.